Terri
Medicare says they will continue coverage of Avastin for breast cancer.
They said that the drug will still be on the market, doctors will still be prescribing it, and medicare will continue to pay for it, adding that CMS often pays for off-label uses of drugs. Will all insurance companies follow the medicare lead?